COPD is caused by damage to the lungs or airways that can lead ... “There’s a variety of different inhalers to use for that, ...

Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.

Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

NCR has given rise to the use of nebulizers among children who are having it tough to breathe. Most hospitals are crowded with children struggling to breathe. Many have asthma or pneumonia, conditions ...

Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

If you’ve been diagnosed with chronic obstructive pulmonary disease, or COPD, you probably have shortness of breath during physical exertion. Regular exercise may seem intimidating, but it’s ...